GH
Guardant HealthCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Successful scaling of commercial tests and favorable reimbursement lifts revenue and margins toward analyst highs.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +1.0.
What can break
Adverse reimbursement decisions limiting commercial uptake
Momentum
96
Value
37
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $113.84 · Bull $175.00 · Bear $55.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-20 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $174.61
Why
Momentum96 · Δ7d +1.0
Value37 · Δ7d +0.1
Sentiment38 · Δ7d +0.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
96
26% active weight
Current posture
7d trendImproving
Δ7d
+1.0
Δ21d
+1.6
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.1
Sentiment
38
34% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-4.4
Why this grade
Composite grade C. Momentum 96.0 / Value 36.5 / Sentiment 37.9
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$20.67B
Beta
1.64
Shares Out
132.6M
P/E (TTM) · Derived
-46.9
P/S (TTM)
14.54
P/FCF (TTM) · Derived
-88.15
Rev YoY
+48.3%
EPS YoY
+11.1%
Gross Margin
+64.9%
Op Margin
-48.1%
Net Debt
$508.54M
Current Ratio
4.68
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology